# Mechanisms of Traumatic Spinal Cord Injury AIS Grade Conversion

**Authors:** Jesse A. Stokum, Riccardo Serra, Nicole Gorny, Bradley Wilhelmy, Timothy J. Chryssikos, Gary Schwartzbauer, Bizhan Aarabi, Volodymyr Gerzanich, J. Marc Simard

PMC · DOI: 10.1089/neur.2025.0035 · Neurotrauma Reports · 2025-06-16

## TL;DR

This paper explores how spinal cord injuries lead to changes in clinical outcomes and what biological processes are involved.

## Contribution

The paper provides a comprehensive review of mechanisms behind AIS grade conversion in spinal cord injury.

## Key findings

- AIS grade conversion occurs in some spinal cord injury patients due to various biological mechanisms.
- Secondary cell death mechanisms like apoptosis and necroptosis contribute to neurological dysfunction.
- Clinical management approaches may help reduce secondary tissue loss after SCI.

## Abstract

Spinal cord injury (SCI) remains a major unsolved problem that permanently impairs the lives of innumerable individuals worldwide. Although advances in the basic, pre-clinical and clinical sciences of SCI hold promise for patients, clinicians may lack a full insight into the relevant cellular and molecular events, and laboratory researchers may underappreciate how cellular and molecular phenomena translate into meaningful functional outcomes. To help bridge these perspectives, we first review the American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade, which is the principal instrument used to gauge clinical outcomes in SCI, and the clinically important concept of AIS grade “conversion” (improvement), which occurs in some but not all patients. We then review underlying mechanisms that contribute to the AIS grade and its conversion, including mechanisms of transient neurological dysfunction (neuronal and axonal “stunning”), mechanisms of secondary cell loss (apoptosis, pyroptosis, and necroptosis), and mechanisms of axonal loss (primary axotomy and secondary axonal degeneration). Finally, we briefly review approaches to clinical management that may ameliorate identified mechanisms of secondary tissue loss and neurological dysfunction following SCI.

## Linked entities

- **Diseases:** spinal cord injury (MONDO:0043797)

## Full-text entities

- **Diseases:** axonal loss (MESH:D012183), neurological dysfunction (MESH:D009461), SCI (MESH:D013119), tissue loss (MESH:D017695), axonal degeneration (MESH:D009410), Impairment (MESH:D060825), Spinal Injury (MESH:D013124), AIS (MESH:D013734)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12235128/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12235128/full.md

## References

221 references — full list in the complete paper: https://tomesphere.com/paper/PMC12235128/full.md

---
Source: https://tomesphere.com/paper/PMC12235128